Lung cancer - What has changed in two decades;Cancro do pulmão - O que mudou em duas décades

Revista Portuguesa de Pneumologia

Volumn 11, Issue 2, 2005, Pages 135-154

  Sucena, Maria ^a   Fernandes, Gabriela ^a   Queiroga, Henrique ^a,b   Hespanhol, Venceslau ^a,b  

^a HOSPITAL DE SÃO JOÃO   (Portugal)

^b University of Porto   (Portugal)

Author keywords

Histology; Lung cancer; Performance status; Stage; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; AGING; ARTICLE; CANCER THERAPY; CIGARETTE SMOKING; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FREQUENCY ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY;

EID: 20144367887     PISSN: 08732159     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0873-2159(15)30494-3     Document Type: Article

References (66)

1. Jemal A, Thomas A, Murray T, et al. Cancer statistics 2002. CA Cancer J Clin 2002; 52: 23-47.
2. Montero C, Rosales M, Otero I, Blanco M, Rodriguez G, Peterga S, Pita S, Verea H. Cancer de pulmon en el área sanitária de A Coruna: incidência, abordaje clínico y supervivencia. Arch Bronconeumol 2003; 39(5): 209-16.
3. Spiro SG, Porter JC. Lung cancer - where are we today? Current advances in staging and nonsurgical treatment. Am J Respir Crit Care Med 2002; 166: 1166-1196.
4. a edição. Editora Permanyer. 2003.
5. Diagnosis and Management of Lung Cancer: ACCP evidence-based guidelines. Chest 2003; 123 no1 (Suppl): 1S-338S.
6. Chung A. Lung cancer cell type and occupational exposure. In: Samet JM, ed. Epidemiology of lung cancer. New York, NY. Marcel Dekker, 1994; 413-436.
7. Charloux A, Quoix E, Wolkove N, Small D, Pauli G, Kreisman H. The increasing incidence of lung Adenocarcinoma: reality or artefact? A review of the epidemiology of lung cancer adenocarcinoma. Int J Epidemiol 1997; 26: 14-23.
8. Vincent RG, Pickren JW, Lane WW, Bross L, Takita H, Honten L, et al. The changing histopathology of lung cancer. Cancer 1977; 39: 1647-55.
9. National Cancer Institute (NCI). The FTC cigarette test method for determining tar, nicotine, and carbon monoxide yields of US cigarettes. Monograph 7. Bethesda, Md: National Institutes of Health, 1996.
10. Wynder EL, Muscat JE. The changing epidemiology of smoking and lung cancer histology. Environ health Perspect 1995; 103(suppl): 143-148.
11. Hoffmann D, Hoffman I. The changing cigarette, 1950-1995. J Toxicol Environ Health 1997; 50: 307-364.
12. a Ed.). World Health Organization. Springer.
13. Oken MM, Creech RH, Torney DC et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5: 649-655
14. Mountain CF. Revision in the International System for Staging Lung Cancer. Chest 1997:111: 1710-7.
15. Sotto-Mayor R. Terapêutica do carcinoma pulmonar não de pequenas células. Rev Port Pneumol 2002; VIII (3): 237-59.
16. Levi F, Franceschi S, La Vecchia C, Randimbison L, Te VC. Lung cancer trends by histological type in Vaud and Neuchâtel, Switzerland, 1974-1994. Cancer 1997; 79: 906-914.
17. Mane JM, Estape J, Sanchez-Lloret J, et al. Age and clinical characteristics of 1433 patients with lung cancer. Age Ageing 1994; 23: 28-31.
18. Silverberg E and Lubera JA. Cancer statistics. CA Cancer J Clin 1988; 38: 5-22.
19. Gridelli C, Perrone F and Monfardini S. Lung cancer in the elderly. Eur J Cancer 1997; 33: 2313-2314.
20. Brown JS, Eraut D, Trask C, Davison AG. Age and the treatment of lung cancer. Thorax 1996; 51: 564-8.
21. Coggon D, Acheson ED. Trends in lung cancer mortality. Thorax 1983; 38: 721-723.
22. Connolly CK, Jones WG, Thorogood J, Head C, Muers MF. Investigation, treatment and prognosis of bronchial carcinoma in the Yorkshire region of England 1976-1983. Br J Cancer 1990; 61: 579-583.
23. Janssen-Heijnen MLG, Gatta G, Forman D, Capocaccia R, Coebergh JWW and the EUROCARE Working Group. Variation in survival of patients with lung cancer in Europe 1985-1989. Eur J Cancer 1998; 34(14): 2191-2196.
24. Janssen-Heijnen MLG, Schipper RM, Razenberg PPA, Crommelin MA, Coeberg JW. Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population-based study. Lung Cancer 1998; 21: 105-113.
25. Balducci L. Geriatric oncology: challenge for the new century. Eur J Cancer 2000; 36: 1741-1754.
26. Fentiman IS, Tirelli V, Monfardini S et al. Cancer in the elderly: why so badly treated? Lancet 1990; 28:1020-1022.
27. Piccirillo JF, Feinstein AR. Clinical symptoms and comorbidity: significance for the prognostic classification of cancer. Cancer 1996; 77: 834-842.
28. Feinstein AR, Wells CK. A clinical-severity staging system for patients with lung cancer. Medicine 1990; 69: 1-33.
29. Doll R, Peto R. Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers. J Epidemiol Community Health 1978; 32:303-313.
30. US Department of Health, and Human Services (US-DHHS), Public Health Service, Centers for Disease Control, and Prevention (CDC). Cigarette smoking: attributable mortality and years of potential life lost, United States, 1950-1990. MMWR Morb Mortal Kkly Rep 1993; 42:37-39.
31. US Department of health, and Human Services (US-DHHS). The health benefits of smoking cessation: a report of the Surgeon General: USDHHS Publication No 90-8416. Washington, DC: US Government Printing Office 1990.
32. Hrubec Z, McLaughlin JK. Former cigarette smoking and mortality among US veterans: a 26-year follow-up, 1954-1980. In: Burns DM, Garfinkel L, samet JM, eds. Changes in cigarette-related disease risks and their implications for prevention and control. Bethesda, MD: US Government Printing Office 1997: 501-530.
33. O'Rourke MA, Feussner JR, Feigl P and Laszlo J. Age trends of lung cancer stage at diagnosis. Implications for lung cancer screening in the elderly. JAMA 1987; 258: 921-926.
34. O'Rourke MA and Crawford J: Lung cancer in the eldlery. Clin Geriatr Med 1987; 3: 595-623.
35. Anton-Culver H, Culver BD, Kurosaki T, Osann KE, Lee JB. Incidence of lung cancer by histological type from a population-based registry. Cancer Res 1988; 48: 6580-3.
36. Devesa SS, Shaw GL, Blot WJ. Changing patterns of lung cancer incidence by histological type. Cancer Epidemiol Biomarkers Prev 1991; 1: 29-34.
37. Zheng T, Holford T, Boyle P, Chen Y, Ward BA, Flannery J, et al. Time trend and the age-period-cohort effect on the incidence of histologic types of lung cancer in Connecticut 1960-1989. Cancer 1994; 74: 1556-7.
38. Travis WD, Travis LB, Devesa SS. Lung cancer. Cancer 1995; Suppl. 75: 191-202.
39. Travis WD, Travis LB, Devesa SS. United States lung carcinoma incidence trends. Declining for most histologic types among males, increasing among females. Cancer 1996; 77: 2464-2470.
40. Dodds L, Davis S, Polissar L. A population based study of lung cancer incidence trends by histological type, 1974-1981. J Natl Cancer Inst 1986; 6: 21-29.
41. Wu AH, Henderson BE, Thomas DC, Mack TM. Secular trends in histologic types of lung cancer. J Natl Cancer Inst 1986; 7: 53-56.
42. Janssen-Heijnen ML, Nab HW, van Reek J, Van der heijden LH, Schipper R, Coebergh JW. Striking changes in smoking behaviour and lung cancer incidence by histological type in south-east Netherlands, 1960-91. Eur J Cancer 1995; 31A: 949-952.
43. Olsen JH. Epidemiology of lung cancer: Eur Respir Mon 1995; 1: 1-17.
44. Seow A, Duffy SW, Ng TP et al. Lung cancer amoung Chinese females in Singapore 1968-1992: time trends, dialect group differences and implications for aetiology Int J Epidemiol 1998; 27: 167-172.
45. Kung ITM, So KF; Lam TH. Lung cancer in Hong Kong Chinese: mortality and histological types, 1973-1982: Br J Cancer 1984; 50: 381-8.
46. Hanai A, Benn T, Fujimoto I, Muir CS. Comparison of lung cancer incidence rates by histological type in high and low incidence countries, with reference to the limited role of smoking. Jpn J Cancer Res (Gann) 1988; 79: 445-52.
47. Rennert G, Rennert HS, Epstein L. Lung cancer histology in major ethnic groups among the jews, Israel, 1962-1982. Eur J Epidemiol 1991; 7: 68-76.
48. Choi JH, Chung HC, Yoo NC, Lee HR, Choi W, et al: Changing trends in histologic types of lung cancer during the last decade (1981-1990) in Korea: a hospital-based study. Lung Cancer 1994; 10: 287-96.
49. Russo A, Crosignani P, Franceschi S, Berrino F. Changes in lung cancer histological types in Varese cancer registry, Italy 1976-1992. Eur J Cancer 1997; 33: 1643-1647.
50. Wynder EL, Hoffmann D. Smoking and lung cancer: scientific challenges and opportunities. Cancer Res 1994; 54: 5284-95.
51. Peto R. Overview of cancer time-trend studies in relation to changes in cigarette manufacture. In: Zaridze D, Peto R, editors. Tobacco: a major international health hazard: IARC Scientific Publication No 74 Lyon: International Agency for Research on Cancer 1986: 211-26.
52. Benhamou S, Benhamou E, Tirmarche M, Flamant R. Lung cancer and use of cigarettes: a French case-control study: J Natl Cancer Inst 1985; 74: 1169-75.
53. Kabat GC, Stellman SD, Wynder EL. Relation between exposure to environmental tobacco smoke and lung cancer in lifetime nonsmokers. Am J Epidemiol 1995; 142: 141-8.
54. Travis DW, Linder J, Mackay B. Classification, histology, cytology, and electron microscopy. In: Pass HJ, Mitchell JB, Johnson DH, Turrisi AT, editors. Lung cancer: principles and practice. Philadelphia: Lippincott-Raven, 1996: 361-95.
55. Carr D. Histopathology of lung cancer. Int J Epidemiol 1990; 19 (Suppl 1): 8-10.
56. Makitaro R, Paakko F, Huhti E, Bloigu R, Kinnula VL. An epidemiological study of lung cancer: history and histological types in a general population in northern Finland. Eur Respir J 1999; 13: 436-440.
57. Byers T, Vena J, Mettlin C, Swanson M, Graham S. Dietary vitamin A and lung cancer risk: an analysis by histological subtypes. Am J Epidemiol 1984; 120: 769-76.
58. Mollo F, Pira E, piolatto G, Bellis D, burlo P, Andreozzi A, et al. Lundg Adenocarcinoma and indicators of asbestos exposure. Int J Cancer 1995; 60: 289-93.
59. Taioh E, Wynder EL. Endocrine factors and adenocarcinoma of the lung in women. J Natl Cancer Inst 1994; 86: 869-70.
60. Charloux A, Rossignal M, Purohit A, et al. International differences in epidemiology of lung carcinoma. Lung Cancer 1997; 16: 133-143.
61. Bouchardy CH, Floretta G, de Perott M et al. determinants of long term survival after surgery for cancer of the lung. Cancer 1999; 86: 2229-2237.
62. Spiro S. Management of lung cancer. Remains surgery for cure of non-small cell and chemotherapy for small cell type. BMJ 1990; 301: 1287-8.
63. Fergusson RJ, Gregor A, Dodds R, Kerr G. Management of lung cancer in South East Scotland. Thorax 1996; 51: 569-574.
64. Damhuis RA, Schutte PR. Resection rates and postoperative mortality in 7899 patients with lung cancer. Eur Respir J 1996; 9: 7-10.
65. Roxburgh JC, Thompson J, Goldstraw P. Hospital mortality and long-term survival after pulmonary resection in the elderly. Ann Thorac Surg 1991; 51: 800-803.
66. Shepherd FA, Carney DN. Treatment of NSCLC: Chemotherapy. In HansenHH (ed): textbook of Lung Cancer. London, Martin Dunitz 2000; 213-242.